Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • BCRP
    (2)
  • ABC Transporter
    (1)
  • AChR
    (1)
  • AMPK
    (1)
  • Autophagy
    (1)
  • CDK
    (1)
  • Dopamine Receptor
    (1)
  • Epigenetic Reader Domain
    (1)
  • Histamine Receptor
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (8)
  • Immune System
    (2)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

T1336

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
Benztropine mesylate
Benztropine methanesulfonate, Benzotropine mesylate, Benzatropine mesylate
T1336132-17-2
Benztropine mesylate (Benztropine methanesulfonate) is a centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
  • $29
In Stock
Size
QTY
XY101
T133622349368-16-5In house
XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).
  • $79
In Stock
Size
QTY
Y06137
T133632226534-49-0In house
Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.
  • $55
In Stock
Size
QTY
YHO-13351 free base
T13365912288-64-3In house
YHO-13351 free base, the water-soluble prodrug of YHO-13177, is an inhibitor of BCRP (breast cancer resistance protein).
  • $30
In Stock
Size
QTY
XRK3F2
T133602375193-43-2
XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.
  • $34
In Stock
Size
QTY
TargetMol | Citations Cited
XY028-133
T133612229974-73-4
XY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
  • $118
In Stock
Size
QTY
YAP/TAZ inhibitor-1
T133642093565-23-0
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor (IC50 <0.100 μΜ) for the study of abnormal immune function and cancer.
  • $487
5 days
Size
QTY
TargetMol | Citations Cited
YHO-13351
YHO13351, YHO 13351
T133661346753-00-1
YHO-13351 is an ABCG2 inhibitor, an acrylonitrile derivative, that induces sensitization of cancer stem/initiating-like side population cells to irinotecan.GSK1702934A can be used to study diabetes.
  • $30
In Stock
Size
QTY
YKL-5-124 TFA (1957203-01-8 free base)
YKL-5-124 TFA
T13367
YKL-5-124 TFA is a potent, selective, irreversible and covalent inhibitor of CDK7 (IC50s of 53.5 nM and 9.7 nM for CDK7 and CDK7/Mat1/CycH, respectively).
  • $1,670
8-10 weeks
Size
QTY
YLF-466D
C24
T133681273323-67-3
YLF-466D (C24) is a novel AMPK activator that inhibits platelet aggregation.
  • $31
In Stock
Size
QTY
YM-264
T13369131888-54-5
YM-264 is a selective and orally active antagonist of platelet-activating factor (PAF) (pKi value of 8.85 for rabbit platelet membranes).
  • $1,520
6-8 weeks
Size
QTY